LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Status: Recruiting
Location: See all (4) locations...
Study Type: Observational
SUMMARY

This study will develop a whole-of-body markerless tracking method for measuring the motion of the tumour and surrounding organs during radiation therapy to enable real-time image guidance. Routinely acquired patient data will be used to improve the training, testing and accuracy of a whole-of-body markerless tracking method. When the markerless tracking method is sufficiently advanced, according to the PI of each of the data collection sites, the markerless tracking method will be run in parallel to, but not intervening with, patient treatments during data acquisition.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Will receive radiation therapy for brain, breast, head and neck, kidney, liver, pancreas, prostate, spine cancer treatment or cardiac arrhythmia treatment at a participating centre.

• Will receive CT planning, and a cone beam CT scan for at least one fraction of radiation therapy.

• Will receive intrafraction x-ray imaging for the liver, pancreas, prostate, spine cancer treatment or cardiac arrhythmia treatment. As intrafraction imaging is not common standard of care for brain, breast, head and neck and kidney cancer treatments there is no requirement to have intrafraction x-ray imaging data for these anatomical sites.

• Provides written informed consent.

Locations
Other Locations
Australia
Alfred Health
NOT_YET_RECRUITING
Melbourne
Peter MacCallum Cancer Centre
NOT_YET_RECRUITING
Melbourne
Royal North Shore Hospital
RECRUITING
Saint Leonards
Princess Alexandra Hospital
NOT_YET_RECRUITING
Woolloongabba
Contact Information
Primary
Shona Silvester
shona.silvester@sydney.edu.au
+61 2 8627 1185
Time Frame
Start Date: 2023-02-28
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 300
Treatments
Brain cancer
Patients having radiation therapy for treatment of brain cancer.
Breast cancer
Patients having radiation therapy for treatment of breast cancer.
Head and neck cancer
Patients having radiation therapy for treatment of head and neck cancer.
Kidney cancer
Patients having radiation therapy for treatment of kidney cancer.
Liver cancer
Patients having radiation therapy for treatment of liver cancer.
Pancreatic cancer
Patients having radiation therapy for treatment of pancreatic cancer.
Prostatic cancer
Patients having radiation therapy for treatment of prostate cancer.
Spinal neoplasm
Patients having radiation therapy for treatment of spinal cancer.
Cardiac arrhythmia
Patients having radiation therapy for treatment of cardiac arrhythmia
Sponsors
Collaborators: Calvary Mater Newcastle, Australia, Austin Health, Western Sydney Local Health District, Princess Alexandra Hospital, Brisbane, Australia, Peter MacCallum Cancer Centre, Australia
Leads: University of Sydney

This content was sourced from clinicaltrials.gov